HTFL

$22.52

Post-MarketAs of Mar 17, 8:00 PM UTC

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$22.52
Potential Upside
5%
Whystock Fair Value$23.65
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryHealth Information Services

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a pat...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.92B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
8.43

Recent News

GuruFocus.com
Mar 17, 2026

Earnings To Watch: HeartFlow Inc (HTFL) Reports Q4 2025 Result

This article first appeared on GuruFocus. HeartFlow Inc (NASDAQ:HTFL) is set to release its Q4 2025 earnings on Mar 18, 2026. The consensus estimate for Q4 2025 revenue is $46.50 million, and the earnings are expected to come in at -$0.27 per share.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Feb 25, 2026

Heartflow, Inc. (HTFL) Announces an Expansion of its GAMEFILM Registry

Heartflow, Inc. (NASDAQ:HTFL) is among the 11 Newly-Listed NASDAQ Stocks to Buy Now. On February 12, 2026, Heartflow, Inc. (NASDAQ:HTFL) announced an expansion of its GAMEFILM Registry. Initially focused on retired National Football League athletes, the study will now include former players from the National Basketball Association and the National Hockey League, broadening the initiative […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 24, 2026

HeartFlow’s GAMEFILM Expansion Links Athlete Heart Data To AI Valuation Story

HeartFlow (NasdaqGS:HTFL) is expanding its GAMEFILM Registry to include retired NBA and NHL athletes. The program focuses on heart health in professional sports, using AI based heart disease assessment technology. HeartFlow is collaborating with organizations that support former professional athletes as part of this registry expansion. For investors watching the intersection of AI and healthcare, HeartFlow is in the cardiology segment, using imaging data and software to assess heart disease...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
TipRanks
Jan 29, 2026

PayPal downgraded, UPS upgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly.Top 5 Upgrades: Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential HSBC upgraded UPS (UPS) to Buy from Hold with a price target of $125, up from $100. Q4

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Jan 10, 2026

HeartFlow (HTFL) Valuation Check After Recent Share Price Momentum And Rich Price To Sales Multiple

HeartFlow stock reaction and recent performance snapshot HeartFlow (HTFL) has drawn attention after its recent share move, prompting investors to look more closely at how its month and past 3 months returns align with the company’s current fundamentals and market expectations. See our latest analysis for HeartFlow. At a share price of $33.14, HeartFlow’s recent 7 day share price return of 14.39% and 30 day share price return of 18.06% contrast with a slightly negative 90 day share price...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.